Affective disorders and anxiety disorders predict the risk of drug harmful use and dependence

Addiction

Volumn 106, Issue 6, 2011, Pages 1126-1134

  Liang, Wenbin ^a   Chikritzhs, Tanya ^a   Lenton, Simon ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Addiction; Affective disorders; Anxiety disorders; Drug dependence; Mental health; Population survey

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; AUSTRALIA; CHILD; COMORBIDITY; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MOOD DISORDER; ONSET AGE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; STATISTICS; TIME;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; AUSTRALIA; CHILD; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MOOD DISORDERS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 79955885949     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03362.x     Document Type: Article

References (42)

1. Burns L., Teesson M. Alcohol use disorders comorbid with anxiety, depression and drug use disorders: findings from the Australian National Survey of Mental Health and Well Being. Drug Alcohol Depend 2002; 68: 299-307.
2. Chan Y. F., Dennis M. L., Funk R. R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat 2008; 34: 14-24.
3. Hall W., Degenhardt L., Teesson M. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base. Addict Behav 2009; 34: 526-30.
4. Darke S., Ross J., Williamson A., Mills K. L., Havard A., Teesson M. Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence. Addiction 2007; 102: 1140-6.
5. Saladin M. E., Brady K. T., Dansky B. S., Kilpatrick D. G. Understanding comorbidity between PTSD and substance use disorders-2 preliminary investigations. Addict Behav 1995; 20: 643-55.
6. Chen X., Stanton B., Li X., Fang X., Lin D. Substance use among rural-to-urban migrants in China: a moderation effect model analysis. Subst Use Misuse 2008; 43: 105-24.
7. Glantz M. D., Anthony J. C., Berglund P. A., Degenhardt L., Dierker L., Kalaydjian A. etal. Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med 2009; 39: 1365-77.
8. Jacobi F., Wittchen H. U., Holting C., Hofler M., Pfister H., Muller N. etal. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34: 597-611.
9. Lynskey M. T., Glowinski A. L., Todorov A. A., Bucholz K. K., Madden P. A. F., Nelson E. C. etal. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 2004; 61: 1026-32.
10. Caspi A., Moffitt T. E., Cannon M., Mcclay J., Murray R., Harrington H. etal. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol Psychiatry 2005; 57: 1117-27.
11. Fergusson D. M., Boden J. M., Horwood L. J. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study. Drug Alcohol Depend 2008; 96: 165-77.
12. Cerda M., Sagdeo A., Galea S. Comorbid forms of psychopathology: key patterns and future research directions. Epidemiol Rev 2008; 30: 155-77.
13. Teesson M., Slade T., Mills K. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2009; 43: 606-14.
14. Teesson M., Hall W., Slade T., Mills K., Grove R., Mewton L. etal. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction 2010; 105: 2085-94.
15. Slade T., Johnston A., Oakley Browne M. A., Andrews G., Whiteford H. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust NZ J Psychiatry 2009; 43: 594-605.
16. Australian Bureau of Statistics (ABS). National Survey of Mental Health and Wellbeing: Summary of Results. Canberra: Australian Bureau of Statistics; 2007.
17. Kessler R. C., Crum R. M., Warner L. A., Nelson C. B., Schulenberg J., Anthony J. C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313-21.
18. Abraham H. D., Fava M. Order of onset of substance abuse and depression in a sample of depressed outpatients. Compr Psychiatry 1999; 40: 44-50.
19. Brady K. T., Dansky B. S., Sonne S. C., Saladin M. E. Posttraumatic stress disorder and cocaine dependence: order of onset. Am J Addict 1998; 7: 128-35.
20. Lieb R., Schuetz C. G., Pfister H., Von Sydow K., Wittchen H.-U. Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 2002; 68: 195-207.
21. Swendsen J., Conway K. P., Degenhardt L., Glantz M., Jin R., Merikangas K. R. etal. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010; 105: 1117-28.
22. Merikangas K. R., Herrell R., Swendsen J., Rossler W., Ajdacic-Gross V., Angst J. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich Cohort Study. Arch Gen Psychiatry 2008; 65: 47-52.
23. Reed P. L., Anthony J. C., Breslau N. Incidence of drug problems in young adults exposed to trauma and posttraumatic stress disorder: do early life experiences and predispositions matter? Arch Gen Psychiatry 2007; 64: 1435-42.
24. Degenhardt L., Hall W. Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug Alcohol Rev 2003; 22: 7-13.
25. Moore T. H. M., Zammit S., Lingford-Hughes A., Barnes T. R. E., Jones P. B., Burke M. etal. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28.
26. Compton W. M., Cottler L. B., Phelps D. L., Ben Abdallah A., Spitznagel E. L. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict 2000; 9: 126-34.
27. Goodwin R. D., Fergusson D. M., Horwood L. J. Association between anxiety disorders and substance use disorders among young persons: results of a 21-year longitudinal study. J Psychiatr Res 2004; 38: 295-304.
28. Becker B., Wagner D., Gouzoulis-Mayfrank E., Spuentrup E., Daumann J. The impact of early-onset cannabis use on functional brain correlates of working memory. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 837-45.
29. De Graaf R., Radovanovic M., Van Laar M., Fairman B., Degenhardt L., Aguilar-Gaxiola S. etal. Early cannabis use and estimated risk of later onset of depression spells: epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol 2010; 172: 149-59.
30. De Hert M., Wampers M., Jendricko T., Franic T., Vidovic D., De Vriendt N. etal. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophr Res 2010; Epub ahead of print.
31. Kalayasiri R., Gelernter J., Farrer L., Weiss R., Brady K., Gueorguieva R. etal. Adolescent cannabis use increases risk for cocaine-induced paranoia. Drug Alcohol Depend 2010; 107: 196-201.
32. Malone D. T., Hill M. N., Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol 2010; 160: 511-22.
33. Tijssen M. J. A., Van Os J., Wittchen H.-U., Lieb R., Beesdo K., Wichers M. Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. Acta Psychiatr Scand 2010; 122: 255-66.
34. Andreasson S., Allebeck P., Angstrom A., Rydberg U. Cannabis use and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483-6.
35. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-3.
36. Fergusson D. M., Horwood L. J., Swain-Campbell N. Cannabis use and psychological adjustment in adolescence and young adulthood. Addiction 2002; 97: 1123-35.
37. Smit F., Bolier L., Cuijpers P. Cannabis use and the later risk of schizophrenia: a review. Addiction 2004; 99: 422-31.
38. Van Os J., Bak M., Hanssen M., Bijl R. V., De Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002; 156: 319-27.
39. Zammitt S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1199-203.
40. O'Connor D. W. Do older Australians truly have low rates of anxiety and depression? A critique of the 1997 National Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2006; 40: 623-31.
41. Trollor J. N., Anderson T. M., Sachdev P. S., Brodaty H., Andrews G. Age shall not weary them: mental health in the middle-aged and the elderly. Aust NZ J Psychiatry 2007; 41: 581-9.
42. Kessler R. C., Angermeyer M., Anthony J. C., Graaf R. D., Demyttenaere K., Gasquet I. etal. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007; 6: 168-76.